| Product Code: ETC13372938 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 0.46 Billion |
| Forecast Size (2032) | USD 0.69 Billion |
| CAGR | 5.90% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | Asia Pacific |
| Fastest Growing Region | Latin America |
| Largest Segment | Viral Disease Detection |
| Fastest Growing Segment | Parasitic Disease Test |
| Leading Companies | Thermo Fisher Scientific, IDEXX Laboratories, Neogen Corporation, PhageTech, AquaCare |

The Global Shrimp Disease Diagnostics Market was estimated at USD 0.46 Billion in 2025 and is projected to reach USD 0.69 Billion by 2032, growing at a CAGR of 5.90% from 2026 to 2032.
The Global Shrimp Disease Diagnostics Market is restructuring itself as aquaculture practices evolve worldwide. An upsurge in shrimp culture is driving the need for precise diagnostic solutions, motivated by an increasing frequency of shrimp diseases. The market is on the brink of transformation, as emphasis on technology leads to enhanced disease management protocols.
Key players are investing in innovative diagnostic technologies that streamline the detection process, promising greater accuracy and efficiency. The surge in consumer demand for shrimp products compels shrimp farmers to adopt advanced diagnostics, making this market critical for the sustainability and profitability of aquaculture.
This graph illustrates the annual growth rates of the Global Shrimp Disease Diagnostics Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 8.93 | Expanding awareness of shrimp disease diagnostics enables increased testing among aquaculture producers. |
| 2023 | 4.66 | A shift toward higher raw material costs changes the pricing of diagnostic kits for shrimp diseases. |
| 2024 | 6.99 | Farmers are adapting to new regulations mandating comprehensive shrimp health monitoring practices. |
| 2025 | 5.25 | An expanding focus on shrimp disease management leads to greater adoption of diagnostic technologies. |
| 2026 | 6.55 | Implementing sustainable practices in shrimp farming emphasizes the need for effective disease diagnostics. |
| 2027 | 6.65 | Regional aquaculture companies are investing in enhanced shrimp disease diagnostics to capture new markets. |
| 2028 | 5.37 | PCR technology advancements drive improvements in shrimp disease diagnostics, enhancing market growth. |
| 2029 | 5.15 | In Southeast Asia, a skilled workforce is crucial for effective shrimp disease diagnostics implementation. |
| 2030 | 5.54 | Aquaculture producers increasingly seek accurate diagnostics solutions for shrimp to navigate supply chain challenges. |
| 2031 | 7.56 | As advancements emerge in shrimp disease diagnostics, innovations are reshaping testing methodologies and applications. |
| 2032 | 4.95 | The consolidation of diagnostic providers creates competitive pressure, leading to pricing adjustments in shrimp disease testing. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
Despite the promising growth, the Global Shrimp Disease Diagnostics Market faces notable challenges. One pressing issue involves the high costs associated with advanced diagnostic technologies, often exceeding USD 2,000 for complete testing solutions. This financial barrier can deter adoption, particularly among small-scale shrimp farmers. For example, many farmers in developing regions report spending a significant portion of their budgets on basic necessities rather than advanced diagnostics, leading to increased vulnerability to disease outbreaks.
Several transformative trends are reshaping the Global Shrimp Disease Diagnostics Market. The integration of molecular diagnostic techniques, such as PCR and NGS, is accelerating the pace of disease detection. For instance, AquaCare has introduced a PCR-based test that claims results in less than two hours, appealing to time-sensitive farmers. Furthermore, the growing role of AI and big data analytics in disease management is noteworthy; companies like Neogen Corporation utilize predictive analytics to forecast disease outbreaks based on environmental conditions, thereby optimizing testing and prevention strategies.
Emerging opportunities within the Global Shrimp Disease Diagnostics Market reveal potential revenue growth avenues. Expanding R&D initiatives aimed at innovative diagnostic solutions are particularly significant. For example, a recent partnership between IDEXX Laboratories and various aquaculture firms aims to develop next-gen rapid test kits, projected to be in commercial use by 2026. The rising emphasis on sustainable aquaculture presents revenue streams related to biosecurity measures, with investments estimated to reach USD 500 million by 2025 to enhance disease prevention.
Viral Disease Detection is anticipated to remain the largest segment in the market, holding approximately ~42% share in 2025. The high prevalence of viral infections among shrimp populations solidifies its market leadership. Conversely, Parasitic Disease Tests are predicted to be the fastest-growing segment, with a CAGR of 7.8% from 2026 to 2032, propelled by increased incidences of parasitic outbreaks and demand for effective management solutions.
PCR testing is currently the leading method for disease diagnostics, accounting for roughly ~45% share in 2025, due to its accuracy and quick turnaround time. Rapid Kits, however, are showing promising growth potential and are expected to witness a CAGR of 6.5% from 2026 to 2032, driven by their convenience and on-site testing capability.
Among various applications, Disease Monitoring remains the largest segment, possessing an estimated ~50% share in 2025, as continuous surveillance is critical for effective disease management. On-site Diagnosis is forecasted to be the fastest-growing application, with a CAGR of 7.0% from 2026 to 2032, as it allows for immediate testing and response, significantly reducing the impact of disease outbreaks.
The Aquaculture sector dominates the end-use market, with a share of around ~60% in 2025, reflecting the industry's reliance on effective disease diagnostics for sustainable production. Government Agencies are experiencing the fastest growth, expected to see a CAGR of 6.7% from 2026 to 2032, as regulatory bodies intensify their focus on biosecurity protocols.
The Asia Pacific region is the largest market, capturing an estimated ~53% share in 2025, largely due to its extensive shrimp aquaculture operations. Latin America is projected to be the fastest-growing region, with a CAGR of 7.2% from 2026 to 2032, driven by increasing investments in aquaculture infrastructure and rising shrimp consumption in domestic markets.
Regulatory and governmental support is pivotal for the Global Shrimp Disease Diagnostics Market. Policies aimed at enhancing disease management in aquaculture often translate into significant investments and standards, bolstering the entire sector.
The Global Shrimp Disease Diagnostics Market is anticipated to experience notable changes driven by technological advancements. Heightened accuracy in disease detection through molecular methods is expected to reshape diagnostic protocols, making them more efficient. For instance, a collaboration between Neogen Corporation and regional aquaculture operators is set to enhance disease management strategies, further solidifying the reliance on proactive monitoring. These developments will likely lead to better disease control measures, ultimately elevating shrimp production standards by 2032.
Recent advancements are contributing significantly to the Global Shrimp Disease Diagnostics Market, with companies focusing on enhancing their product offerings and operational capabilities.
The competitive structure of the Global Shrimp Disease Diagnostics Market is diverse, featuring a mixture of established corporations and emerging players. This competition fosters innovation and a dynamic shift towards advanced diagnostic solutions tailored for aquaculture needs.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Thermo Fisher Scientific | Pioneering PCR technology for rapid diagnostics. | Expanding molecular testing capabilities across global markets. |
| IDEXX Laboratories | Expertise in veterinary diagnostics and aquaculture. | Developing next-gen rapid response test kits. |
| Neogen Corporation | Innovations in food safety and animal health. | Leveraging AI for predictive analytics in disease management. |
| PhageTech | Advanced bacteriophage-based diagnostic technologies. | Focusing on niche markets in shrimp disease diagnostics. |
| AquaCare | Rapid testing solutions for aquaculture. | Increasing market presence in Latin America. |
The interplay among these key players is vital for advancing diagnostic methodologies, each contributing uniquely to a more resilient aquaculture framework.
Global Shrimp Disease Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Shrimp Disease Diagnostics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Shrimp Disease Diagnostics Market Revenues & Volume, 2022 & 2032F |
3.3 Global Shrimp Disease Diagnostics Market - Industry Life Cycle |
3.4 Global Shrimp Disease Diagnostics Market - Porter's Five Forces |
3.5 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.7 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By Testing Method, 2022 & 2032F |
3.8 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.9 Global Shrimp Disease Diagnostics Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 Global Shrimp Disease Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Shrimp Disease Diagnostics Market Trends |
6 Global Shrimp Disease Diagnostics Market, 2022-2032 |
6.1 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Viral Disease Detection, 2022-2032 |
6.1.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Bacterial Infection Test, 2022-2032 |
6.1.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Fungal Infection Test, 2022-2032 |
6.1.5 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Parasitic Disease Test, 2022-2032 |
6.1.6 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Others, 2022-2032 |
6.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By PCR, 2022-2032 |
6.2.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By ELISA, 2022-2032 |
6.2.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Microscopy, 2022-2032 |
6.2.5 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Rapid Kits, 2022-2032 |
6.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Disease Monitoring, 2022-2032 |
6.3.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Routine Testing, 2022-2032 |
6.3.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Water Quality Control, 2022-2032 |
6.3.5 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By On-site Diagnosis, 2022-2032 |
6.3.6 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Laboratory Testing, 2022-2032 |
6.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2022-2032 |
6.4.1 Overview & Analysis |
6.4.2 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Aquaculture, 2022-2032 |
6.4.3 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Research Institutes, 2022-2032 |
6.4.4 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Hatcheries, 2022-2032 |
6.4.5 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Government Agencies, 2022-2032 |
6.4.6 Global Shrimp Disease Diagnostics Market, Revenues & Volume, By Fisheries, 2022-2032 |
7 North America Shrimp Disease Diagnostics Market, Overview & Analysis |
7.1 North America Shrimp Disease Diagnostics Market Revenues & Volume, 2022-2032 |
7.2 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
7.3 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2022-2032 |
7.4 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2022-2032 |
7.5 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2022-2032 |
7.6 North America Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2022-2032 |
8 Latin America (LATAM) Shrimp Disease Diagnostics Market, Overview & Analysis |
8.1 Latin America (LATAM) Shrimp Disease Diagnostics Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2022-2032 |
8.4 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2022-2032 |
8.5 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2022-2032 |
8.6 Latin America (LATAM) Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2022-2032 |
9 Asia Shrimp Disease Diagnostics Market, Overview & Analysis |
9.1 Asia Shrimp Disease Diagnostics Market Revenues & Volume, 2022-2032 |
9.2 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
9.2.2 China Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
9.3 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2022-2032 |
9.4 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2022-2032 |
9.5 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2022-2032 |
9.6 Asia Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2022-2032 |
10 Africa Shrimp Disease Diagnostics Market, Overview & Analysis |
10.1 Africa Shrimp Disease Diagnostics Market Revenues & Volume, 2022-2032 |
10.2 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
10.3 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2022-2032 |
10.4 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2022-2032 |
10.5 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2022-2032 |
10.6 Africa Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2022-2032 |
11 Europe Shrimp Disease Diagnostics Market, Overview & Analysis |
11.1 Europe Shrimp Disease Diagnostics Market Revenues & Volume, 2022-2032 |
11.2 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
11.2.3 France Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
11.3 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2022-2032 |
11.4 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2022-2032 |
11.5 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2022-2032 |
11.6 Europe Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2022-2032 |
12 Middle East Shrimp Disease Diagnostics Market, Overview & Analysis |
12.1 Middle East Shrimp Disease Diagnostics Market Revenues & Volume, 2022-2032 |
12.2 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Shrimp Disease Diagnostics Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By Type, 2022-2032 |
12.4 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By Testing Method, 2022-2032 |
12.5 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By Application, 2022-2032 |
12.6 Middle East Shrimp Disease Diagnostics Market, Revenues & Volume, By End Use, 2022-2032 |
13 Global Shrimp Disease Diagnostics Market Key Performance Indicators |
14 Global Shrimp Disease Diagnostics Market - Export/Import By Countries Assessment |
15 Global Shrimp Disease Diagnostics Market - Opportunity Assessment |
15.1 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By Type, 2022 & 2032F |
15.3 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By Testing Method, 2022 & 2032F |
15.4 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By Application, 2022 & 2032F |
15.5 Global Shrimp Disease Diagnostics Market Opportunity Assessment, By End Use, 2022 & 2032F |
16 Global Shrimp Disease Diagnostics Market - Competitive Landscape |
16.1 Global Shrimp Disease Diagnostics Market Revenue Share, By Companies, 2025 |
16.2 Global Shrimp Disease Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here